@erinha-ri.bsky.social
European Research Infrastructure on Highly Pathogenic Agents - ERINHA AISBL
Fostering research to prevent pandemics
https://erinha.eu
@erinha-ri.bsky.social🦠A Phase I trial of a Bundibugyo Ebola vaccine candidate has begun in Uganda to assess safety and immune responses—a key step towards new prevention tools.
@erinha-ri.bsky.social🌍 ERINHA & #INTERCEPTOR featured in a biosafety panel at #GHS2026 in Kuala Lumpur this June.
The conference brought together 1,240 delegates from 88 countries and territories.
Final report here 👇https://www.ghsconf.com/wp-content/uploads/2026/10/GHSC2026-Post-Conference-Report-compressed.pdf
@erinha-ri.bsky.social🧬 CCHFVACIM’s 3rd annual meeting brought partners together in Thessaloniki on 8 October to discuss viral antigens, immunity, preclinical models, mRNA vaccines and monoclonal antibodies against CCHF.
Read our meeting recap 👇
@erinha-ri.bsky.social🦇 HENIPROTECT aims to develop inhaled antibodies against Nipah virus.
ERINHA contributes its high-containment research expertise to this new six-year project.
Funded by the European Union.
@erinha-ri.bsky.social🦠In Iraq, veterinary and health teams are coordinating seasonal tick-control campaigns to reduce CCHF risk. It’s a clear example of why animal and human health must work together.
https://shafaq.com/en/society/Iraq-tightens-livestock-disease-measures
#ERINHA #CCHF #OneHealth #InfectiousDiseases
@erinha-ri.bsky.social🌍 Infectious diseases cross borders. Cuts to global health funding weaken surveillance and outbreak response, warns the French Académie des sciences. Research and cooperation matter.
https://www.academie-sciences.fr/rapport-menaces-sur-laide-internationale-en-sante-ampleur-et-enjeux
@erinha-ri.bsky.social🦠US measles cases reach 3,471 in 2026—52% above the 2025 total. Vaccination, surveillance and public trust remain essential.
@erinha-ri.bsky.social🦠Ebola in the DRC: transmission continues as clinical research advances. Antiviral development and international cooperation remain essential.
WHO update:
https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON617
@erinha-ri.bsky.social📢 New research opportunity!
ISIDORe II has launched its first call for proposals, dedicated to Andes virus & #hantavirus research.
🔬 Free access to leading European research infrastructures
💻 Information webinar: 28 Sept., 14:00–15:30 CEST
👇 Learn more at isidore-project.eu/news/isidore...
@erinha-ri.bsky.social🦠What medical countermeasures are being developed against hantaviruses?
A new article reviews progress in vaccines, neutralising antibodies and antiviral treatments.
Co-authored by Johan Neyts, member of ERINHA’s General Assembly (KU Leuven).
@erinha-ri.bsky.socialTwo measles-associated deaths reported in Pennsylvania are not yet included in the US national count while the CDC reviews their causes.
Reliable outbreak surveillance requires transparent, consistent reporting, and public trust.
